Localization and function of the cannabinoid CB1 receptor in the anterolateral bed nucleus of the stria terminalis

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Puente, Nagore ^a   Elezgarai, Izaskun ^a   Lafourcade, Mathieu ^b   Reguero, Leire ^a   Marsicano, Giovanni ^b   Georges, François ^b   Manzoni, Olivier J ^b   Grandes, Pedro ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b INSTITUT FRANÇOIS MAGENDIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CANNABINOID 1 RECEPTOR; VESICULAR GLUTAMATE TRANSPORTER 1; CANNABINOID; GLUTAMIC ACID;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BEHAVIOR; BRAIN REGION; BRAIN SLICE; CELL ULTRASTRUCTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTRON MICROSCOPY; ELECTROPHYSIOLOGY; EX VIVO STUDY; KNOCKOUT MOUSE; MORPHOLOGICAL TRAIT; MOUSE; MUTANT; NONHUMAN; PATCH CLAMP; PRESYNAPTIC MEMBRANE; RAT; RECORDING; STRESS; STRIA TERMINALIS; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION; WHOLE CELL; ANIMAL; IN VITRO STUDY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; SEPTUM NUCLEUS; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

MUS; RATTUS;

ANIMALS; CANNABINOIDS; GLUTAMIC ACID; MICE; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; SEPTAL NUCLEI;

EID: 77749242544     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008869     Document Type: Article

References (56)

1. McElligott ZA, Winder DG (2009) Modulation of glutamatergic synaptic transmission in the bed nucleus of the stria terminalis. Prog Neuropsychopharmacol Biol Psych 33: 1329-1335.
2. Delfs JM, Zhu Y, Druhan JP, Aston-Jones G (2000) Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403: 430-434.
3. Stewart J (2000) Pathways to relapse: the neurobiology of drug- and stressinduced relapse to drug-taking. J Psych Neurosci 25: 125-136.
4. Dumont EC, Mark GP, Mader S, Williams JT (2005) Self-administration enhances excitatory synaptic transmission in the bed nucleus of the stria terminalis. Nat Neurosci 8: 413-414.
5. Harris GC, Aston-Jones G (2007) Activation in extended amygdala corresponds to altered hedonic processing during protracted morphine withdrawal. Behav Brain Res 176: 251-258.
6. Bangasser DA, Shors TJ (2008) The bed nucleus of the stria terminalis modulates learning after stress in masculinized but not cycling females. J Neurosci 28: 6383-6387.
7. Olsen CM, Huang Y, Goodwin S, Ciobanu DC, Lu L, et al. (2008) Microarray analysis reveals distinctive signaling between the bed nucleus of the stria terminalis, nucleus accumbens, and dorsal striatum. Physiol Genomics 32: 283-298.
8. Dong HW, Petrovich GD, Swanson LW (2001a) Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res Rev 38: 192-246.
9. Herman JP, Cullinan WE (1997) Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 20: 78-84.
10. McDonald AJ, Shammah-Lagnado SJ, Shi C, Davis M (1999) Cortical afferents to the extended amygdala. Ann N Y Acad Sci 877: 309-338.
11. Dong HW, Petrovich GD, Watts AG, Swanson LW (2001b) Basic organization of projections from the oval and fusiform nuclei of the bed nuclei of the stria terminalis in adult rat brain. J Comp Neurol 436: 430-455.
12. Dong HW, Swanson LW (2004) Organization of axonal projections from the anterolateral area of the bed nuclei of the stria terminalis. J Comp Neurol 468: 277-298.
13. Larriva-Sahd J (2006) Histological and cytological study of the bed nuclei of the stria terminalis in adult rat. II. Oval nucleus: extrinsic inputs, cell types, neuropil, and neuronal modules. J Comp Neurol 497: 772-807.
14. Georges F, Aston-Jones G (2002) Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: a novel excitatory amino acid input to midbrain dopamine neurons. J Neurosci 22: 5173-5187.
15. Massi L, Elezgarai I, Puente N, Reguero L, Grandes P, et al. (2008) Cannabinoid receptors in the bed nucleus of the stria terminalis control cortical excitation of midbrain dopamine cells in vivo. J Neurosci 28: 10496-10508.
16. Chevaleyre V, Takahashi KA, Castillo PE (2006) Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci 29: 37-76.
17. Mackie K (2008) Cannabinoid receptors: where they are and what they do. J Neuroendocrinol 20: 10-14.
18. Mackie K (2007) Understanding cannabinoid psychoactivity with mouse genetic models. PLoS Biol 5: e280.
19. Grueter BA, Gosnell HB, Olsen CM, Schramm-Sapyta NL, Nekrasova T, et al. (2006) Extracellular-signal regulated kinase 1-dependent metabotropic glutamate receptor 5-induced long-term depression in the bed nucleus of the stria terminalis is disrupted by cocaine administration. J Neurosci 26: 3210-3219.
20. Patel S, Roelke CT, Rademacher DJ, Cullinan WE, Hillard CJ (2004) Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 145: 5431-5438.
21. Kathuria S, Gaetani S, Fegley D, Valiño F, Duranti A, et al. (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9: 76-81.
22. Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, et al. (2005) Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci USA 102: 18620-18625.
23. Hill MN, Gorzalka BB (2005) Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test. Eur Neuropsychopharmacol 15: 593-599.
24. Matsuda LA, Bonner TI, Lolait SJ (1993) Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 327: 535-550.
25. Grueter BA, Winder DG (2005) Group II and III metabotropic glutamate receptors suppress excitatory synaptic transmission in the dorsolateral bed nucleus of the stria terminalis. Neuropsychopharmacology 30: 1302-1311.
26. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, et al. (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418: 530-534.
27. Monory K, Massa F, Egertová M, Eder M, Blaudzun H, et al. (2006) The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51: 455-466.
28. Monory K, Blaudzun H, Massa F, Kaiser N, Lemberger T, et al. (2007) Genetic dissection of behavioural and autonomic effects of Delta(9)- tetrahydrocannabinol in mice. PLoS Biol 5(10): e269.
29. Fremeau RT Jr, Voglmaier S, Seal RP, Edwards RH (2004) VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate. Trends Neurosci 27: 98-103.
30. Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, et al. (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350: 240-244.
31. Hoffman AF, Riegel AC, Lupica CR (2003) Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus. Eur J Neurosci 18: 524-534.
32. Robbe D, Alonso G, Duchamp F, Bockaert J, Manzoni OJ (2001) Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J Neurosci 21: 109-116.
33. Robbe D, Kopf M, Remaury A, Bockaert J, Manzoni OJ (2002) Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc Natl Acad Sci U S A 99: 8384-8388.
34. Mailleux P, Vanderhaeghen JJ (1992) Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48: 655-668.
35. Tsou K, Brown S, Sañudo-Peña MC, Mackie K, Walker JM (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83: 393-411.
36. Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, et al. (2001) Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 21: 9506-9518.
37. Nyíri G, Cserép C, Szabadits E, Mackie K, Freund TF (2005) CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons. Neuroscience 136: 811-822.
38. Tamamaki N, Yanagawa Y, Tomioka R, Miyazaki J, Obata K, et al. (2003) Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse. J Comp Neurol 467: 60-79.
39. Katona I, Urbán GM, Wallace M, Ledent C, Jung KM, et al. (2006) Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci 26: 5628-5637.
40. Kawamura Y, Fukaya M, Maejima T, Yoshida T, Miura E, et al. (2006) The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J Neurosci 26: 2991-3001.
41. Yoshida T, Fukaya M, Uchigashima M, Miura E, Kamiya H, et al. (2006) Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoylglycerol, and presynaptic cannabinoid CB1 receptor. J Neurosci 26: 4740-4751.
42. Lafourcade M, Elezgarai I, Mato S, Bakiri Y, Grandes P, et al. (2007) Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex. PLoS ONE 2: e709.
43. Mátyás F, Urbán GM, Watanabe M, Mackie K, Zimmer A, et al. (2008) Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. Neuropharmacology 54: 95-107.
44. Clapper JR, Mangieri RA, Piomelli D (2009) The endocannabinoid system as a target for the treatment of cannabis dependence. Neuropharmacology 56 Suppl 1: 235-243.
45. Lovinger DM (2008) Presynaptic modulation by endocannabinoids. Handb Exp Pharmacol 184: 435-477.
46. Fortin DA, Levine ES (2007) Differential effects of endocannabinoids on glutamatergic and GABAergic inputs to layer 5 pyramidal neurons. Cereb Cortex 17: 163-174.
47. Piomelli D (2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4: 873-884.
48. Puente, et al. (2009) Production of 2-arachidonoylglycerol and anandamide by separate signals mediate different forms of synaptic plasticity in a single neuron. IV European Workshop on Cannabinoid Research. Abstract Book. 60 p.
49. Egli RE, Kash TL, Choo K, Savchenko V, Matthews RT, et al. (2005) Norepinephrine modulates glutamatergic transmission in the bed nucleus of the stria terminalis. Neuropsychopharmacology 30: 657-668.
50. Erb S, Shaham Y, Stewart J (1996) Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology 128: 408-412.
51. Shaham Y, Erb S, Stewart J (2000) Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Rev 33: 13-33.
52. Aston-Jones G, Delfs JM, Druhan J, Zhu Y (1999) The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal. Ann N Y Acad Sci 877: 486-498.
53. Navarro M, Hernández E, Muñoz RM, del Arco I, Villanúa MA, et al. (1997) Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat. Neuroreport 8: 491-496.
54. Arévalo C, de Miguel R, Hernández-Tristán R (2001) Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters. Pharmacol Biochem Behav 70: 123-131.
55. Haller J, Bakos N, Szirmay M, Ledent C, Freund TF (2002) The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. Eur J Neurosci 16: 1395-1398.
56. Martin JR, Ballard TM, Higgins GA (2002) Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety. Pharmacol Biochem Behav 71: 615-625.